Back

5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (1) Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Pernille Tilma Tonnesen

Aarhus University Hospital, Aarhus (Denmark)

6 More presentations in this session

Presentation thumbnail
Cholesterol and risk of ST-segment elevation versus non-ST-segment elevation myocardial infarction: a population-based cohort study
Professor M. Maeng (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Which feature of the metabolic syndrome is better predictor for coronary artery disease morbidity and mortality; a prospective 10-year analysis
Associate Professor L. Bikdelu (Mashhad, IR)
Abstract Slides Video
Presentation thumbnail
Low dose colchicine for secondary prevention in patients with previous atherosclerotic event: a systematic review and meta-analysis of randomised trials
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Enhancing the precision of lipid management quality assessment in ASCVD using large language models
Doctor D. Nguyen (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Suboptimal lipid measurement and statin use after percutaneous coronary intervention according to socioeconomic status and ethnicity: a subanalysis of the DISCOVER registry
Doctor F. Bruno (Turin, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
thumbnail
Congress Presentation
Cardiovascular outcomes in a SELECT-like obesity population: real-world insights from the swedish AROS study
thumbnail
Congress Presentation
Relationship between baseline LDL cholesterol levels and cardiovascular outcomes in adults with cardiovascular disease and overweight or obesity: an exploratory analysis of the SELECT trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources